NICE approves drugs for Alzheimer's diseaseBMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7280.190/b (Published 27 January 2001) Cite this as: BMJ 2001;322:190
- Zosia Kmietowicz
Health authorities and trusts in England and Wales have been told to end the rationing of drugs to treat Alzheimer's disease and to make them available to all patients in whom they might slow the progression of the disease.
The National Institute for Clinical Excellence (NICE) last week issued guidance on the drugs donepezil (Aricept), rivastigmine (Exelon), and galantamine (Reminyl), saying that drug treatment should now form one component of care in people with mild to moderate symptoms.
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial